Concepedia

Jan‐Peter Kramb

JK

Statistics

Publications

3

Citations

223

H-Index

3

Active since

2008

Affiliations

Chulabhorn Research Institute(Current)

Jan‐Peter Kramb is an author at Chulabhorn Research Institute specializing in cancer pharmacology, medicine, and pharmacology.

Publications per year

2008–2012

3

Publications

3

Vanillin Suppresses Metastatic Potential of Human Cancer Cells through PI3K Inhibition and Decreases Angiogenesis in Vivo

Kriengsak Lirdprapamongkol, Jan‐Peter Kramb, Tuangporn Suthiphongchai et al. · Journal of Agricultural and Food Chemistry · 2009 · 158 citations

Medicine, Oncology, Pharmacology +13

Novel 3-Azaindolyl-4-arylmaleimides Exhibiting Potent Antiangiogenic Efficacy, Protein Kinase Inhibition, and Antiproliferative Activity

Christopher Ganser, Eva Lauermann, Annett Maderer et al. · Journal of Medicinal Chemistry · 2012 · 37 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

Juice of eclipta prostrata inhibits cell migration in vitro and exhibits anti-angiogenic activity in vivo.

Kriengsak Lirdprapamongkol, Jan‐Peter Kramb, Daranee Chokchaichamnankit et al. · PubMed · 2008 · 28 citations

Medicine, Oncology, Pharmacology +17

1–3 of 3